Many Americans continue to face symptoms of Long COVID. After testing negative, inflammation caused by the virus ... DocWire News recently spoke with Dr. Thomas Lendvay, Co-Founder and Chief Medical Officer of Tend, a company dedicating ... The CardioNerds cover how to make a rapid but thorough evaluation of cardiogenic shock. A recent study proposed that gut microbiota composition may contribute to the pathogenesis of immune thrombocytopenia ... A new study found that certain treatments for non-hematological cancers may be associated with changes and disruptions ... Patients with rheumatoid arthritis (RA) and those who are at high risk for the disease had a distinctly different oral ... Fecal microbiota transplant (FMT) is a relatively safe and viable treatment option for acute gut graft-versus-host ... Recent research has identified correlations between the gut microbiota and increased odds of obesity, metabolic ... Here are the top-read hematology/oncology stories covered by DocWire News in 2019.
... Administering a dose of the common antibiotic vancomycin before radiation therapy may help immune cells kill tumors, ... Exposure to certain types of oral antibiotics might be linked to an increase risk of Parkinson’s disease (PD), ... According to a new study published in Microbiome, the answer to systemic lupus erythematosus (SLE) flare ups in pregnant ... A group of Harvard researchers has recently created a probiotic hydrogel that can function as a Band-Aid-like seal for ... Serum zonulin was found to be upregulated in patients with irritable bowel syndrome (IBS) with levels comparable to ... Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. A study published in Cancer Research found that gut bacteria can play a role in breast cancer metastasis. Researchers ... New research has shown that coffee suppressed bacteria and increased muscle motility in an animal study, regardless of ... According to Michael Pignanelli, BMSc, and colleagues, variations in atherosclerosis burden can only be partly ... Amgen announced that its new osteoporosis drug romosozumab-aqqg (Evenity) will be priced at $1,825 per monthly dose, or ... According to Michael Pignanelli, BMSc, and colleagues, variations in atherosclerosis burden can only be partly explained ...